CrossrefInfokarte
Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors
Journal of Medical Cases · 2022-11 · 13 (11) · 530-535
DOI: 10.14740/jmc4008 ↗Abstract
Kein Abstract verfügbar.
EUVIMED